COLFAX CORP (CFX) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:CFX - Common Stock
CFX Key Statistics, Chart & Performance
The current stock price of CFX is 39.06 null. In the past month the price increased by 7.54%. In the past year, price decreased by -10.02%.
CFX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CFX. When comparing the yearly performance of all stocks, CFX is a bad performer in the overall market: 61.5% of all stocks are doing better.
CFX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CFX. CFX may be in some trouble as it scores bad on both profitability and health.
CFX Financial Highlights
Over the last trailing twelve months CFX reported a non-GAAP Earnings per Share(EPS) of 2.13. The EPS increased by 53.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.86% | ||
| ROA | 0.84% | ||
| ROE | 1.55% | ||
| Debt/Equity | 0.45 |
CFX Forecast & Estimates
19 analysts have analysed CFX and the average price target is 51.43 null. This implies a price increase of 31.66% is expected in the next year compared to the current price of 39.06.
For the next year, analysts expect an EPS growth of 241.51% and a revenue growth 7.2% for CFX
CFX Ownership
CFX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PH | PARKER HANNIFIN CORP | 33.27 | 119.16B | ||
| ITW | ILLINOIS TOOL WORKS | 25.55 | 76.43B | ||
| SYM | SYMBOTIC INC | 518.54 | 40.03B | ||
| XYL | XYLEM INC | 30.19 | 35.58B | ||
| OTIS | OTIS WORLDWIDE CORP | 22.83 | 35.14B | ||
| IR | INGERSOLL-RAND INC | 27.38 | 34.83B | ||
| DOV | DOVER CORP | 22.19 | 28.34B | ||
| SNA | SNAP-ON INC | 18.95 | 18.79B | ||
| FTV | FORTIVE CORP | 16.76 | 17.46B | ||
| RBC | RBC BEARINGS INC | 45.81 | 15.77B | ||
| NDSN | NORDSON CORP | 26.55 | 15.28B | ||
| MLI | MUELLER INDUSTRIES INC | 20.85 | 14.75B |
Related stock screener links
About CFX
Company Profile
Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.
Company Info
COLFAX CORP
2711 Centerville Road, Suite 400
Wilmington DELAWARE 20701 US
CEO: Matthew L. Trerotola
Employees: 16200
Phone: 13022529160.0
COLFAX CORP / CFX FAQ
Can you describe the business of COLFAX CORP?
Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.
What is the stock price of COLFAX CORP today?
The current stock price of CFX is 39.06 null. The price decreased by -3.77% in the last trading session.
Does COLFAX CORP pay dividends?
CFX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CFX stock?
CFX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists CFX stock?
CFX stock is listed on the New York Stock Exchange exchange.
How is the valuation of COLFAX CORP (CFX) based on its PE ratio?
The PE ratio for COLFAX CORP (CFX) is 18.34. This is based on the reported non-GAAP earnings per share of 2.13 and the current share price of 39.06 null.
Can you provide the market cap for COLFAX CORP?
COLFAX CORP (CFX) has a market capitalization of 6.10B null. This makes CFX a Mid Cap stock.